MiR-23a-5p通过向调节RAGE-ROS通路来缓解慢性阻塞性肺病
Chenli Chang1,2, Ke Huang2, Xia Xu3
1China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Respiratory research
|February 20, 2024
概括
这项研究揭示了一条涉及miR-23a-5p和RAGE在慢性阻塞性肺病 (COPD) 发展中的新途径. 增加miR-23a-5p水平可以降低COPD的严重程度,提供潜在的新疗法.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因.
- 高级甘氨酸最终产品的受体 (RAGE) 在COPD的发病过程中发挥着关键作用,特别是与香烟烟雾暴露有关.
- 了解RAGE的miRNA调节对于开发COPD新型治疗策略至关重要.
研究的目的:
- 研究微RNA (miRNA) 在调节COPD中RAGE表达中的作用.
- 为了确定参与香烟烟雾引起的COPD病变的特定miRNAs.
- 探索针对已识别的miRNA-RAGE轴的治疗潜力.
主要方法:
- 在COPD患者和小鼠的肺组织以及人类支气管上皮细胞中的量化RAGE表达.
- 利用COPD患者的外周血液上的RNA测序来识别RAGE的潜在miRNA调节者.
- 采用体内 (COPD小鼠) 和体内 (16-HBE细胞) 模型来评估miR-23a-5p和RAGE抑制的功能.
- 分析了下游的信号通路,包括活性氧物种 (ROS) 和ERK激活.
主要成果:
- 在COPD肺部,COPD小鼠和香烟烟雾提取物 (CSE) 治疗的细胞中,RAGE表达显著增加;RAGE抑制减少了COPD的严重程度.
- RNA-seq确定miR-23a-5p是与RAGE相互作用的关键miRNA,在COPD模型中显著下调.
- 在体内和体外恢复miR-23a-5p水平减少了呼吸道炎症,改善了肺功能,并抑制了RAGE/ROS/ERK信号传递.
结论:
- 一个新的miR-23a-5p/RAGE/ROS信号轴被确定为COPD病变发生的关键.
- MiR-23a-5p作为RAGE和下游反应性氧物种 (ROS) 信号的负调节剂.
- 针对这一轴,特别是通过增加miR-23a-5p,显示了COPD治疗的治疗前景.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
273
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
273
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206


